United States · FDA National Drug Code directory
NIVAGEN ZINC OXIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 75834-170_9b087880-cd9b-4a0e-be76-dcb0ad2fd11f
- Product NDC
- 75834-170
- Form
- OINTMENT
- Composition / generic term
- zinc oxide
- Labeler
- Nivagen Pharmaceuticals, Inc.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20180510
- Source listing expiry
- 20261231
Source-listed ingredients
- ZINC OXIDE — 200 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 28.4 g in 1 TUBE (75834-170-01) · 75834-170-01
- 56.7 g in 1 TUBE (75834-170-02) · 75834-170-02
- 425 g in 1 JAR (75834-170-15) · 75834-170-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →